Morgan Stanley »

Denali Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $20M 982k 20.63
2023-06-30 $32M 1.1M 29.51
2022-12-31 $12M 433k 27.83
2022-06-30 $12M 423k 29.32
2022-03-31 $0 706k 0.00
2021-06-30 $34M 431k 78.47
2020-12-31 $18M 219k 83.71
2020-09-30 $11M 305k 35.77
2020-06-30 $7.7M 319k 24.20
2020-03-31 $2.7M 155k 17.54
2019-12-31 $4.3M 249k 17.42
2019-09-30 $2.5M 163k 15.29
2019-03-31 $3.1M 132k 23.23
2018-12-31 $4.2M 204k 20.67
2018-09-30 $4.1M 187k 21.74
2018-06-30 $1.8M 118k 15.24
2018-03-31 $1.6M 82k 19.70
2017-12-31 $30k 1.7k 17.86